Germany

Peptides and German law: what the Arzneimittelgesetz says

In short

About 8 minutes for the short version; 13 with every detail open.

  • A peptide sold to heal, slim or build muscle is likely to count as a medicine in Germany.
  • Selling a medicine with no licence is a crime. So is selling a fake or dangerous one.
  • Few routes let such medicines in. The medicines law does not name self-use as a crime.
  • Owning a large amount of TB-500 and some other listed peptides for doping in sport is a crime.
  • Patients and doctors can report side effects to the BfArM online.
Last reviewed
A large stone building with columns, four corner towers and a glass dome, with German flags, in evening light.
The Reichstag in Berlin. The German parliament meets here. Photo: Jürgen Matern, Own work(JMatern_071104_8454-8458_WC.jpg) (Wikimedia Commons) CC BY-SA 3.0 Image details

Each section starts with the short answer. The rest is folded under “In detail”.

What does German law say about peptides?

Most peptides sold online likely count as medicines with no licence. Selling them is a crime.
German law forbids selling a medicine with no licence. The medicines law does not name using one. Arzneimittelgesetz (AMG), Heilmittelwerbegesetz (HWG) and Anti-Doping-Gesetz (AntiDopG), in the versions in force on 22 October 2026.
Under German law
Is selling it, or offering it for sale, forbidden?Yes A ready-made medicine needs a licence before it is sold.1,2 Selling one without it is a crime.3
Is advertising it forbidden?Yes Ads for a medicine that needs a licence but has none are not allowed.4
Is bringing it into Germany forbidden?Yes As a rule, only licensed medicines may come in, and only to pharmacies and traders. The exceptions are narrow.5
Are fakes and dangerous medicines treated more strictly?Yes Trading in them can bring up to three years in prison.6,7
Does the medicines law name using it yourself as a crime?No It bans using a dangerous medicine on another person. It does not name using one on yourself.8,7
Can owning it be a crime?Yes Under the anti-doping law, for some listed peptides: owning a large amount for doping in sport.9,10

The Arzneimittelgesetz (AMG) is the German Medicines Act. This page explains what it says about products such as BPC-157, TB-500 or “research” semaglutide. It also covers the anti-doping law, which reaches further in Germany than in the Netherlands.9,11 The page does not tell you how to get round the law. German medicines law follows EU law: see the EU.

What counts as a medicine

Is a peptide a medicine under German law?

Often, yes. The law looks at how a product is offered and at what it can do.
German law has two tests. A product that meets either one is a medicine.
TestThe question the law asks
PresentationIs the product offered as something that heals, relieves or prevents disease in people?
FunctionCan it be used in people to restore, correct or change how the body works, through a drug-like effect?
In case of doubtCould it be a medicine and also a food or a cosmetic? Then it counts as a medicine.

These tests come from § 2 of the AMG.12 They look at the whole product, not only its label. See research use only for why a “research” label does not change this.

In detail: The words of § 2, and two terms you will meet , about 1 minute to read

Under § 2, a medicine is a substance meant for use in or on the human body. It is presented as something that heals, relieves or prevents disease. A substance is also a medicine if it can be used in or on the body, or given to a person, to restore, correct or influence body functions. The effect must be pharmacological, immunological or metabolic.12

Two more terms matter on this page:2

  • Fertigarzneimittel (“ready-made medicine”): a medicine made in advance and sold in a pack meant for the user. A vial sold online is a typical example, in our reading.
  • Inverkehrbringen (“placing on the market”): keeping stock to sell or hand over, offering it, and handing it to others. All of these count, not only the sale itself.

The core rule: a licence before sale

What exactly does the law forbid?

Selling or handing over a ready-made medicine with no licence is banned. So are fakes.
The rules that apply before a medicine may be sold in Germany.
  1. A licence first. A ready-made medicine may only be put on the market with a licence from the German federal authority or from the EU.1
  2. “On the market” is broad. Keeping stock to sell, offering it and handing it over all count.2
  3. No dangerous medicines. A medicine is banned if science gives good reason to suspect harm beyond what medicine finds acceptable.8
  4. No fakes or poor quality. Making or trading in falsified or poor-quality medicines is banned. So are misleading claims.6
  5. Narrow exceptions. Some medicines made in a pharmacy, medicines in clinical trials and compassionate use are the main ones.1 See legal routes.

For BPC-157, the US medicines agency found no approved product in any country.13 So no German licence exists for it. In our reading, none of the exceptions covers selling it as a ready-made product.

In detail: How high the penalties can be , about 1 minute to read
WhatWhere in the lawThe most the law allows
Selling a ready-made medicine without a licenceAMG § 96 no. 5Up to one year in prison, or a fine3
Selling a dangerous medicine, or using it on someone elseAMG § 95Up to three years, or a fine. One to ten years in very serious cases, such as putting many people’s health at risk7
Trading in fake or poor-quality medicinesAMG § 95Up to three years, or a fine7
Bringing a fake medicine into GermanyAMG § 96 no. 18eUp to one year, or a fine3
Bringing in a medicine against the import ruleAMG § 97An administrative fine of up to €25,00014
Advertising a medicine with no licenceHWG § 15An administrative fine of up to €50,00015

An administrative fine (Ordnungswidrigkeit) is a fine from an authority. It is not a criminal conviction. These are maximums. They say what the law allows, not what usually happens.

Bringing medicines into Germany

Can a peptide be sent to me in Germany, or brought in?

As a rule, only licensed medicines may come in, to pharmacies and traders. The exceptions are narrow.
The ways a medicine can come into Germany, and what § 73 of the AMG says about each.
Way inWhat § 73 saysFor a peptide with no licence
A parcel from a shop to youOnly licensed medicines, and only from an EU or EEA pharmacy allowed to sell by mailNot covered: the medicine itself has no licence
From another EU or EEA country, for your own useOnly if it may be sold in the country it comes from, in a normal personal amount, with no business acting in betweenHard to meet when the product is not licensed there either (our reading)
In your luggage when you enter GermanyNot covered by the import ban, in an amount that fits normal personal needThis exception does not mention a licence. The bans on dangerous and fake medicines, and the doping law, still apply
Through a German pharmacy, on your orderA pharmacy may import a medicine that is lawfully sold where it comes from, if Germany has no matching medicineOnly for medicines licensed somewhere
A fake medicineNever allowedNever allowed

Even where the import ban does not apply, other rules still do. Fake medicines may never be brought in. And the anti-doping law limits owning some peptides (see below).5,9

In detail: The exact conditions in § 73 , about 2 minutes to read
  • The main rule (§ 73(1)). A medicine that needs a licence may only be brought in if it is licensed for Germany. The person receiving it must be a drug company, a wholesaler or a pharmacy. Or, for parcels to a private person, it must come from an EU or EEA pharmacy that may sell by mail.5
  • Fakes (§ 73(1b)). Bringing falsified medicines or active substances into Germany is forbidden.5
  • Research (§ 73(2) no. 2). The main rule also does not apply to medicines for the own needs of research and science institutions, needed for scientific work. The text is about institutions, not private buyers.5
  • Personal exceptions (§ 73(2) no. 6 and 6a). The main rule does not apply to medicines brought in when you enter Germany, in an amount for normal personal need. It also does not apply to medicines from an EU or EEA country that may be sold there. They must be bought without a business in between, in such an amount.5
  • What still applies (§ 73(4)). Under these exceptions, most of the AMG does not apply. But the bans on dangerous medicines (§ 5) and on fakes (§ 8) still do.5
  • Pharmacy import (§ 73(3)). A pharmacy may bring in an unlicensed ready-made medicine in small amounts for one person’s order. It must be lawfully sold in the country it comes from, and no matching medicine may be available in Germany. From outside the EU or EEA, a prescription is needed.5
  • The fine. Bringing in medicines against the main rule is an administrative offence, with a fine of up to €25,000.14

Advertising, and why this site sells nothing

Can anyone advertise these products in Germany?

No. Ads for a medicine that needs a licence but has none are not allowed.

Ads for a medicine with no licence can bring a big fine

€50,000

the most a fine can be for an ad for a medicine with no licence

What was counted Heilmittelwerbegesetz § 15(3), for breaches of § 3a, in the version in force on 22 October 2026 Source Heilmittelwerbegesetz (HWG), § 15 (Ordnungswidrigkeiten)15

The Heilmittelwerbegesetz (HWG) is the German law on advertising for medicines. It forbids ads for medicines that need a licence but have none.4 Ads for prescription-only medicines may only be aimed at doctors, pharmacists and others who may trade in them.16 This site sells nothing and names no seller. The Dutch page explains why that matters under EU law.

The anti-doping law

Does the German doping law matter if I am not an athlete?

Partly. Owning a large amount of some listed peptides for doping in sport is a crime for anyone.
Six peptides on this site are named in the annex of the German doping law. AntiDopG annex (last changed 10 March 2023) and the 2026 doping list as published in the German law gazette. Checked on 22 October 2026.
Named in the annex (owning a large amount)?On the doping list the law follows (selling, giving, self-doping)?
TB-500Yes As thymosin beta-4 and its derivatives10Yes Section S217
CJC-1295, tesamorelinYes As growth-hormone-releasing hormones10Yes Section S217
Ipamorelin, hexarelinYes As growth-hormone secretagogues and releasing peptides10Yes Section S217
AOD-9604Yes As a growth-hormone fragment10Yes Section S217
BPC-157No Not in the annex10Yes Section S017
MOTS-cNo Not in the annex10Yes Section S417
Semaglutide, tirzepatideNo Not in the annex10No Not banned; only monitored18

The Anti-Doping-Gesetz (AntiDopG) has three main rules, and they cover different people. Only one of them, the rule on owning a large amount, depends on the annex. The other two follow the full doping list, which Germany publishes each year in its law gazette.9,19,17

In detail: The three rules, who they cover, and the penalties , about 2 minutes to read
RuleWho it coversWhat it bansThe most the law allows
§ 2(1)AnyoneMaking, trading, selling, handing over or prescribing a substance on the doping list, for doping in sportUp to three years, or a fine. One to ten years, for example for supply to someone under 18, or as a business or a gang9,20
§ 2(3)AnyoneBuying, owning or bringing in a “nicht geringe Menge” (a large amount) of a substance in the annex, for doping in sportUp to three years, or a fine. Up to one year if by negligence9,20
§ 3For the penalty: only elite athletes in a testing pool, or people who earn a lot from sportUsing a listed substance without medical need to gain an advantage in an organised competition. Buying or owning it for thatUp to three years for using it. Up to two years for buying or owning it. No penalty for owning it if you give it up before use19,20

The rule on owning a large amount does not say you must be an athlete or take part in competitions. Those limits appear only in the self-doping rule.9,20 It does require the purpose of doping in sport. How courts read “sport” for gym use is a question for our legal reviewer.

In detail: What a 'nicht geringe Menge' is, and why we do not print the amounts , about 1 minute to read

A separate regulation, the Dopingmittel-Mengen-Verordnung, sets the amount for each substance or group in the annex. It covers growth-hormone fragments, growth-hormone-releasing hormones, secretagogues, releasing peptides, and thymosin beta-4 and its derivatives.21

We do not print the amounts. This site gives no amounts of any kind. Below the amount, the rule on owning does not apply, but the other rules on this page still can.

The health ministry adds substances to the annex by regulation.22 The annex was last changed in March 2023. New peptides on the yearly doping list are not in it unless a regulation adds them.10,22

See sport and doping for the sports rules themselves, such as testing and bans.

Who enforces the law

Who enforces these rules?

The health authorities of the German states watch the trade. Police, customs and prosecutors pursue crimes.
Who does what when the law on medicines is broken in Germany.
WhoWhat they do
BfArM, the federal medicines instituteInforms the public about fakes found in the legal supply chain. Can order a recall in urgent cases23
Health authorities of the states (Länder)Supervise the trade in medicines. Seize and test products23
Police, customs and public prosecutorsInvestigate and prosecute crimes involving medicines23

The BfArM keeps a register of pharmacies that may sell medicines by mail. They must show the EU safety logo.23 The BfArM deals only with fakes in the legal supply chain. It cannot seize or test products itself. That is the job of the state authorities, and crimes are a matter for police, customs and prosecutors.23

In detail: What tests of seized products in Germany found , about 1 minute to read

From 2010 to 2013, the Cologne anti-doping laboratory tested 337 black-market products, working with German customs. Of what it found, 12.8% (about one in eight) was peptide hormones or growth factors, mostly growth hormone and growth-hormone-releasing peptides. Thymosin beta-4 was among the findings. The authors wrote that several substances were “of fake/non-approved nature”.24

If your product did not come from a pharmacy, no regulator has checked what is in it. See product risk for what you can and cannot check yourself.

Where to report

Where can I report a side effect in Germany?

To the BfArM and the Paul-Ehrlich-Institut. Use their online portal or a paper form.

Side effects. The BfArM and the Paul-Ehrlich-Institut run one portal for reports: nebenwirkungen.bund.de. Reports from patients and from doctors both help to show a medicine’s risks. You can also send a paper form.25 The portal had a fault from 7 to 9 October 2026. If you reported online then, the institutes ask you to report again.25

Before you report. Keep the vial, its label and any papers. Write down the batch number. Tell your doctor what you use: see talking to your doctor.

Sources

Every claim on this page links to one of these sources. Scholarly sources link to their DOI; regulatory sources to the regulator's own page.

In detail: All 25 sources, numbered as in the text , about 3 minutes to read
  1. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 21 Zulassungspflicht. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 20 October 2026 ↩
  2. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 4 Sonstige Begriffsbestimmungen. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  3. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 96 Strafvorschriften. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  4. Bundesministerium der Justiz (2026). Heilmittelwerbegesetz (HWG), § 3a. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  5. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 73 Verbringungsverbot. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  6. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 8 Verbote zum Schutz vor Täuschung. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  7. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 95 Strafvorschriften. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  8. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 5 Verbot bedenklicher Arzneimittel. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  9. Bundesministerium der Justiz (2026). Gesetz gegen Doping im Sport (Anti-Doping-Gesetz – AntiDopG), § 2 Unerlaubter Umgang mit Dopingmitteln. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 20 October 2026 ↩
  10. Bundesministerium der Justiz (2023). Gesetz gegen Doping im Sport (Anti-Doping-Gesetz – AntiDopG), Anlage (zu § 2 Absatz 3). gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 20 October 2026 ↩
  11. Dopingautoriteit (Doping Authority Netherlands) (2026). Doping en de wet. Web page dopingautoriteit.nl (opens an external site) — accessed 22 October 2026 ↩
  12. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 2 Arzneimittelbegriff. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  13. U.S. Food and Drug Administration (2026). FDA Briefing Document for BPC-157-Related Bulk Drug Substances (BPC-157 (free base) and BPC-157 acetate), Pharmacy Compounding Advisory Committee meeting, 23–24 July 2026. Regulator fda.gov (opens an external site) — accessed 20 October 2026 ↩
  14. Bundesministerium der Justiz (2026). Arzneimittelgesetz (AMG), § 97 Bußgeldvorschriften. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  15. Bundesministerium der Justiz (2026). Heilmittelwerbegesetz (HWG), § 15 (Ordnungswidrigkeiten). gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  16. Bundesministerium der Justiz (2026). Heilmittelwerbegesetz (HWG), § 10. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  17. Bundeskanzleramt (2025). Bekanntmachung der Neufassung der Anlage I zu dem Internationalen Übereinkommen vom 19. Oktober 2005 gegen Doping im Sport / des Anhangs zu dem Übereinkommen vom 16. November 1989 gegen Doping, vom 18. Dezember 2025. Bundesgesetzblatt 2025 Teil II Nr. 312 (23 December 2025). Law recht.bund.de (opens an external site) — accessed 22 October 2026 ↩
  18. World Anti-Doping Agency (2025). The 2026 Monitoring Program. Regulator wada-ama.org (opens an external site) — accessed 20 October 2026 ↩
  19. Bundesministerium der Justiz (2023). Anti-Doping-Gesetz (AntiDopG), § 3 Selbstdoping. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  20. Bundesministerium der Justiz (2023). Anti-Doping-Gesetz (AntiDopG), § 4 Strafvorschriften. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  21. Bundesministerium für Gesundheit (2023). Verordnung zur Festlegung der nicht geringen Menge von Dopingmitteln (Dopingmittel-Mengen-Verordnung – DmMV) vom 10. März 2023. gesetze-im-internet.de (BGBl. 2023 I Nr. 67, S. 5). Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  22. Bundesministerium der Justiz (2015). Anti-Doping-Gesetz (AntiDopG), § 6 Verordnungsermächtigungen. gesetze-im-internet.de. Law gesetze-im-internet.de (opens an external site) — accessed 22 October 2026 ↩
  23. Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) (2026). Arzneimittelfälschungen. Regulator bfarm.de (opens an external site) — accessed 22 October 2026 ↩
  24. Krug O, Thomas A, Walpurgis K, Piper T, Sigmund G, Schänzer W, Laussmann T, Thevis M (2014). Identification of black market products and potential doping agents in Germany 2010-2013. European Journal of Clinical Pharmacology 70:1303-1311. Research article doi:10.1007/s00228-014-1743-5 (opens an external site) ↩
  25. Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) (2026). Nebenwirkungen und weitere Arzneimittelrisiken melden. Regulator bfarm.de (opens an external site) — accessed 22 October 2026 ↩